KelleyMowattDO

Hematologic Oncology

Heme/Onc Fellow

Dr. Mowatt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
Rutgers Health/Newark Beth Israel Medical CenterChief Residency, Internal Medicine, 2019 - 2020
Rutgers Health/Newark Beth Israel Medical CenterResidency, Internal Medicine, 2017 - 2020
Philadelphia College of Osteopathic MedicineClass of 2017
University of Southern CaliforniaMS, Cell and neurobiology, 2009 - 2011
Fordham UniversityBA, Natural science, 2005 - 2009

PubMed

3 citations
New-onset persistent hyperglycemia with initiation of brentuximab treatment.
Joseph Quintas, Kelley B Mowatt, Jamie A Mullally, Amir Steinberg
Journal of Oncology Pharmacy Practice. 2023-04-28
182 citations
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.
Robert L. Fine, Anthony Paul Gulati, Benjamin A. Krantz, Rebecca A. Moss, Stephen M. Schreibman
Cancer Chemotherapy and Pharmacology. 2013-01-31
8 citations
Treatment of Multiple Endocrine Neoplasia 1/2 Tumors: Case Report and Review of the Literature
Anthony Paul Gulati, Benjamin A. Krantz, Rebecca A. Moss, Wendy N Moyal, Dawn Tsushima
Oncology. 2013-01-01

Journal Articles

Incidental Krukenberg Tumor During Cesarean Section
Victor Delgado-Lazo; Rizwana Syed; Kelley B. Mowatt; Andrea Popescu-Martinez, Annals of Internal Medicine: Clinical Cases, 10/4/2022

Abstracts/Posters

New Onset Persistent Hyperglycemia with Initiation of Brentuximab Treatment
JB Quintas, KB Mowatt, JA Mullally, A Steinberg, Blood, 2021
Education Program to Improve the Adherence to Guidelines for Use of Blood Transfusions in Sickle Cell Disease
J Zeppieri, DD Park, K Mowatt, M Sharif, AJ Cohen, Blood, 2019
Sickle Cell Disease and the Adherence to Guidelines for Use of Transfusions
Park DD, Jacob DG, Adedemola A, Mowatt K, Persaud T, Tipirneni A, Carson C, Cohen AJ, Blood, 2017
Prospective phase II study of capecitabine and temozolomide (CAPTEM) for progressive, moderately, and well-differentiated metastatic neuroendocrine tumors.
RL Fine, AP Gulati, D Tsushima, KB Mowatt, A Oprescu, JN Bruce, JA Chabot, Journal of Clinical Oncology, 2014
Curcumin both inactivates and induces selenoprotein thioredoxin reductase: dual regulation influences curcumin-induced apoptosis in prostate cancer cells
R Gopalakrishna, JE Schiffman, K Mowatt, U Gundimeda, Cancer Res, 4/15/2011
Join now to see all